Treatment interruption during radiation therapy: Experience at a single institution in the Republic of Korea
- 4 August 2016
- journal article
- research article
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 13 (5) , E481-E488
Abstract
Aim: Our study analyzed the frequency and causes of treatment interruption among patients undergoing radiation therapy (RT).Methods: A total of 1637 RT courses in 1500 patients were reviewed from September 2009 to October 2013. A continuous break over 7 days or a discontinuous break over 14 days was regarded as a temporary break and RT under 80% of planned treatment was regarded as incomplete.Results: Two‐hundred and twenty courses (13.4%) with treatment interruption were identified. Half of the patients received RT with a definitive aim, and the other half for palliative care. Completion after temporary break, near completion and incompletion were noticed in 12.3%, 21.3%, and 66.4% of cases, respectively. Among patients with a definite aim, thorax (19.2%) and abdomen (16.3%) had a higher interruption rate. For brain and bone with a palliative aim, the frequency of interruption was about 16%. Old age and worse performance negatively affected interruption. The most common cause of treatment interruption was cancer progression including death (30%) and the next was treatment‐related side effects (23.1%).Conclusion: About 13% of RT cases were interrupted. Two third of patients received less than 80% of the planned RT. To improve RT completion rate, multidirectional efforts are needed.Keywords
This publication has 21 references indexed in Scilit:
- Quality assurance and quality control for radiotherapy/medical oncology in Europe: Guideline development and implementationEuropean Journal of Surgical Oncology, 2013
- Ten-year results of quality assurance in radiotherapy chart roundBMC Health Services Research, 2013
- Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010Cancer Research and Treatment, 2013
- Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vesselsNature Communications, 2012
- Non-adherence to guidelines for preoperative testing in a secondary care hospital in AustriaEuropean Journal of Anaesthesiology, 2011
- Treatment Interruption and Discontinuation in Radiotherapy for Rectal CancerCancer Investigation, 2010
- What will be the radiotherapy machine capacity required for optimal delivery of radiotherapy in Scotland in 2015?European Journal of Cancer, 2007
- Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non–small-cell lung carcinoma: Analysis of the Radiation Therapy Oncology Group (RTOG) experienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- The Effect of Treatment Interruptions in the Postoperative Irradiation of Breast CancerOncology, 2005
- The role of radiotherapy in cancer treatmentCancer, 2005